MENU
+Compare
STIM
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$4.13
Change
-$0.67 (-13.96%)
Capitalization
141.64M

STIM Neuronetics Forecast, Technical & Fundamental Analysis

a developer of non-invasive therapies for psychiatric and neurological disorders

STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for STIM with price predictions
Feb 21, 2025

Aroon Indicator for STIM shows an upward move is likely

STIM's Aroon Indicator triggered a bullish signal on February 21, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 251 similar instances where the Aroon Indicator showed a similar pattern. In of the 251 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for STIM moved above the 200-day moving average on February 03, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where STIM advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for STIM moved out of overbought territory on February 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

STIM broke above its upper Bollinger Band on February 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STIM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.212) is normal, around the industry mean (23.448). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.944) is also within normal values, averaging (41.230).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STIM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
STIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

STIM is expected to report earnings to fall 45.16% to -24 cents per share on March 11

Neuronetics STIM Stock Earnings Reports
Q4'24
Est.
$-0.24
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.06
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.07
The last earnings report on November 12 showed earnings per share of -43 cents, missing the estimate of -23 cents. With 1.78M shares outstanding, the current market capitalization sits at 141.64M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive therapies for psychiatric and neurological disorders

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3222 Phoenixville Pike
Phone
+1 610 640-4202
Employees
203
Web
https://www.neurostar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BARIX100.03N/A
N/A
Baron Asset Instl
JGYAX12.18N/A
N/A
JHancock Global Shareholder Yield A
SDIVX27.26N/A
N/A
Stock Dividend
IVNQX45.43N/A
N/A
Invesco Nasdaq 100 Index R6
IBSAX19.77-0.29
-1.45%
VY® Baron Growth A

STIM and Stocks

Correlation & Price change

A.I.dvisor tells us that STIM and DIZTF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STIM and DIZTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STIM
1D Price
Change %
STIM100%
-13.96%
DIZTF - STIM
31%
Poorly correlated
N/A
FNA - STIM
27%
Poorly correlated
-0.23%
NEO - STIM
26%
Poorly correlated
-6.41%
ACRS - STIM
25%
Poorly correlated
-3.03%
IART - STIM
24%
Poorly correlated
-4.09%
More